                         SEQUENCE LISTING

<110>  Ventana Medical Systems, Inc.
       University of Cincinnati
       Mirza, Mana
       Shaughnessy, Elizabeth
       Hurley, John K.
       Vanpatten, Kristie  A.
       Pestano, Gary
       Weber, Georg F.
 
<120>  GRADING, STAGING, AND PROGNOSING CANCER USING OSTEOPONTIN-C

<130>  7668-79777-02

<150>  60/980,379
<151>  2007-10-16

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for OPN-a

<400>  1
atctcctagc cccacagaat                                                   20


<210>  2
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for OPN-a

<400>  2
catcagactg gtgagaatca tc                                                22


<210>  3
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for OPN-b

<400>  3
atctcctagc cccagagac                                                    19


<210>  4
<211>  23
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for OPN-b

<400>  4
aaaatcagtg accagttcat cag                                               23


<210>  5
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for OPN-c

<400>  5
tgaggaaaag cagaatgctg                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for OPN-c

<400>  6
gtcaatggag tcctggctgt                                                   20


<210>  7
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for beta-Actin

<400>  7
ggcggcacca ccatgtaccc t                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for beta-Actin

<400>  8
aggggccgga ctcgtcatac t                                                 21


<210>  9
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for Ck-19

<400>  9
cccgcgacta cagccacta                                                    19


<210>  10
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for Ck-19

<400>  10
ctcatgcgca gagcctgtt                                                    19


<210>  11
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for aP2

<400>  11
tcagtgtgaa tggggatgtg                                                   20


<210>  12
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for aP2

<400>  12
gtggaagtga cgcctttcat                                                   20


<210>  13
<211>  26
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for GAPDH

<400>  13
tgaaggtcgg agtcaacgga tttggt                                            26


<210>  14
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for GAPDH

<400>  14
catgtgggcc atgaggtcca ccac                                              24


<210>  15
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for osteopontin

<400>  15
caaacgccga ccaagggaaa ac                                                22


<210>  16
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide primer for osteopontin

<400>  16
cttctttctc agtttattgg t                                                 21


